Real Insights: How Real-World Evidence Can Support Mental Health Innovation

Mental health disorders remain the highest unmet medical need, surpassing cancer. In the United States alone, more than 10 million adults indicate an unmet need in mental health treatment. Researchers and scientists are expanding current approved therapeutics in new indications as well as looking at non-traditional technologies to help patients dealing with mental health issues [....]

Free

Protecting Our Future: Spurring Innovation to Support Pediatric Preparedness

With COVID-19, we’ve seen our preparedness response tested, and the question remains, how can we be better prepared to protect some of the most vulnerable members of our communities, our babies and children, from future threats? Unfortunately, less innovation takes place in the pediatric space due barriers in the discovery and development environment, including, ethical [....]

Free

Join the Force: An Info Session on the JLABS @ Washington, DC and the BLUE KNIGHT™ Collaboration

BLUE KNIGHT™, a collaboration between Johnson & Johnson Innovation – JLABS and the Biomedical Advanced Research and Development Authority (BARDA), offers emerging life science companies an opportunity to join the JLABS incubator ecosystem with additional support from BARDA. BLUE KNIGHT™ companies, selected for their mutual alignment to Johnson & Johnson and BARDA areas of interest, [....]

Free

[VIRTUAL] Blue Knight™ Symposium with J&J Innovation – JLabs

Virtual Event Virtual Event

In seeking to combat emerging infectious diseases and other 21st-century health threats, the path to better prepared, protected, and healthy individuals, families, and communities could rely on unlocking the collective power of the global community. BLUE KNIGHT™ seeks to answer this call.

Developing Alternative Administration Techniques for Therapeutics and Vaccines

Virtual Event Virtual Event

Expanding the mechanisms for administering therapeutics and vaccines may have the potential to disrupt the status quo and improve availability and accessibility of therapeutic and preventive treatments. This session will explore opportunities for alternative delivery mechanisms and novel innovations which aim to provide alternative methods of administration, including micro-array patches and nasal and oral/sublingual administration. [....]

Free

Solving the Unsolvable: Could Quantum and other Non-traditional Computing hold the key to accelerating drug development?

GoToWebinar

Full-scale quantum computers could have the potential to revolutionize many industries, solving previously computationally impossible problems and uncovering unimaginable new possibilities. So why wouldn’t we apply this tool to try and solve the world's greatest healthcare problems? This promising, new technology could simulate larger, more complex molecules, and could simultaneously review multiple molecules, proteins, and [....]

Free

Let’s Discuss the “still” Soaring Healthcare Investments in 2021 and beyond

GoToWebinar

Jonny’s back! Despite the continuation of COVID -19 through 2021, 2021 was a spectacular year for venture fundraising. Investment in every healthcare sector set records, and most experienced record IPO activity as well. With pullback in both investments and public market performance in late 2021, what will 2022 have in store? Jon will provide his [....]

Free